***Background.*** Alcohol use among HIV and hepatitis C virus (HCV) co-infected patients may influence uptake of newer HCV treatment and impact outcomes. Using a Rapid electronic Survey Tool (ReST), we characterized alcohol use in a cohort of HIV/HCV co-infected and HIV mono-infected patients. We hypothesized that co-infected patients would use less alcohol due to education and other healthcare interventions related to alcohol\'s known effects on liver disease progression.

***Methods.*** The retrospective cohort included patients who attended ≥2 clinic visits at the Vanderbilt Comprehensive Care Clinic, had HCV testing, and completed ≥1 ReST survey between 2008 and 2011. The ReST was administered at each clinic visit to quantify alcohol and drug use in the last 7 days by self-report. Incidence rate ratios (IRR) for alcohol and drug use were obtained by negative binomial regression adjusting for HIV/HCV co-infection, age, race, sex, antiretroviral therapy (ART) use, and HIV risk factor (injection drug use \[IDU\], men having sex with men \[MSM\], or other).

***Results.*** Among 2,448 patients, 15% had HIV/HCV co-infection, and 87% had ReST data from ≥1 visit. Compared to HIV mono-infected, HIV/HCV co-infected patients were older (p \< 0.001), more likely to be female (p = 0.01), more likely to identify IDU as their primary HIV risk factor (39% vs 3%, p \< 0.001), and had a lower mean CD4 nadir (187 vs 228, p \< 0.001). Forty three percent of co-infected patients reported alcohol use in the last 7 days vs 48% of mono-infected (p = 0.13). Only cocaine use differed significantly between co-infected and mono-infected patients (12% vs 5%, p \< 0.001). In adjusted analysis, alcohol use was more frequent among MSM (IRR 1.7, p \< 0.001), but was not associated with co-infection (IRR 1.0, p = 0.7). Cocaine use was reported more frequently among persons with an IDU HIV risk (IRR 2.4, p = 0.005), but also was not associated with co-infection (IRR 1.3, p = 0.3). Both alcohol (IRR 0.8, p \< 0.001) and cocaine use (IRR 0.4, p = 0.03) were less frequent among those prescribed ART.

***Conclusion.*** Reported use of alcohol in the last 7 days was high in both HIV mono-infected and HIV/HCV co-infected patients in this cohort. Alcohol use is likely to affect future HCV treatment decisions and outcomes even with the availability of more effective therapies.
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